Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: NRXS )

2.590 -0.100 (-3.71%)
Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,396
Open 2.650
Bid (Size) 2.300 (1)
Ask (Size) 2.620 (1)
Prev. Close 2.690
Today's Range 2.050 - 2.700
52wk Range 2.000 - 3.890
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024
Neuraxis just reported results for the second quarter of 2024. 
Via InvestorPlace
NRXS Stock Earnings: Neuraxis Reported Results for Q1 2024
Neuraxis just reported results for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+1.97%
+1.97%
1 Month
-13.66%
-13.66%
3 Month
-1.14%
-1.14%
6 Month
-16.45%
-16.45%
1 Year
+3.60%
+3.60%

More News

Read More
NRXS Stock Earnings: Neuraxis Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For April 9, 2024
Via Benzinga
With Only 1.21 Million In The Trading Float, NeurAxis Stock Volatility Exposes An Opportunity, Not A Deterrent ($NRXS)
Via AB Newswire
Exposures Product Safety
SoftBank-Owned Arm, Instacart File To Go Public
Via Talk Markets
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome
Via Benzinga
CEO Spotlight: NeurAxis CEO Explains His Better Way Of Treating Pediatric IBS And FAP ($NRXS)
Via AB Newswire
NeurAxis Looks To Revolutionize The Treatment Of Adolescent Stomach Issues
Via Benzinga
EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids
Via Benzinga
NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023
From NeurAxis, Inc.
Via GlobeNewswire
Alcoholic Beverage Marketing Company LQR Debuts On Nasdaq
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.
Via ACCESSWIRE
NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin
From NeurAxis, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.